181 related articles for article (PubMed ID: 10996621)
1. Cancer vaccines 2000.
Tartour E; Fridman WH
Immunol Lett; 2000 Sep; 74(1):1-3. PubMed ID: 10996621
[No Abstract] [Full Text] [Related]
2. Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.
Schreiber TH; Raez L; Rosenblatt JD; Podack ER
Semin Immunol; 2010 Jun; 22(3):105-12. PubMed ID: 20226686
[TBL] [Abstract][Full Text] [Related]
3. Review: cancer immunotherapy by exosome-based vaccines.
Hao S; Moyana T; Xiang J
Cancer Biother Radiopharm; 2007 Oct; 22(5):692-703. PubMed ID: 17979572
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccines and immunotherapy.
Tang H
Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
[No Abstract] [Full Text] [Related]
5. Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting.
Gray A; Yan L; Kast WM
Mol Interv; 2010 Aug; 10(4):197-203. PubMed ID: 20729485
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines.
Carrabba M; Parmiani G; Rivoltini L
Tumori; 2000; 86(5 Suppl 2):S33-7. PubMed ID: 11195301
[No Abstract] [Full Text] [Related]
8. Unique human tumor antigens: immunobiology and use in clinical trials.
Parmiani G; De Filippo A; Novellino L; Castelli C
J Immunol; 2007 Feb; 178(4):1975-9. PubMed ID: 17277099
[TBL] [Abstract][Full Text] [Related]
9. Cancer vaccines: what do we need to measure in clinical trials?
Kudrin A
Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines: toward the next revolution in cancer therapy.
Emens LA
Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
[No Abstract] [Full Text] [Related]
11. Antitumor vaccination using peptide based vaccines.
Eisenbach L; Bar-Haim E; El-Shami K
Immunol Lett; 2000 Sep; 74(1):27-34. PubMed ID: 10996624
[TBL] [Abstract][Full Text] [Related]
12. Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccines.
Dupont B
Immunol Rev; 2002 Oct; 188():5-8. PubMed ID: 12445276
[No Abstract] [Full Text] [Related]
13. Immunological therapy of human tumors by gene-modified cellular vaccines.
Parmiani G
Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
[No Abstract] [Full Text] [Related]
14. Priming anticancer active specific immunotherapy with dendritic cells.
Mocellin S
Curr Opin Investig Drugs; 2005 Jun; 6(6):576-81. PubMed ID: 15988908
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in cancer therapy.
Parmiani G; Rivoltini L; Andreola G; Carrabba M
Immunol Lett; 2000 Sep; 74(1):41-4. PubMed ID: 10996626
[TBL] [Abstract][Full Text] [Related]
16. Critical issues in the clinical testing of cancer vaccines: summary of a panel discussion at a symposium entitled "Cancer Vaccines: Are They Here Yet?" conducted in Toronto, Canada, December 2002.
Berinstein N
Semin Oncol; 2003 Jun; 30(3 Suppl 8):37-8. PubMed ID: 12881811
[No Abstract] [Full Text] [Related]
17. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
18. Paradigm shifts in cancer vaccine therapy.
Schlom J; Gulley JL; Arlen PM
Exp Biol Med (Maywood); 2008 May; 233(5):522-34. PubMed ID: 18375829
[TBL] [Abstract][Full Text] [Related]
19. Developing enabling technologies for the success of cancer immunotherapy.
Sznol M
Curr Opin Investig Drugs; 2004 Dec; 5(12):1239-42. PubMed ID: 15648943
[No Abstract] [Full Text] [Related]
20. Cancer vaccine clinical trials.
Mannan S
Immunotherapy; 2016 Nov; 8(11):1263-1264. PubMed ID: 27993086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
